Pharmacokinetics, Pharmacodynamic, Safety and Tolerability of Fazamorexant, a Novel Dual Orexin Receptor Antagonist: Report of the First-in-Human Study
Jun Ni,1 Lu Jin,2 Dong Zhao,1 Wen Zhang,1 Baoshun Li,1 Xingxing Huang,2 Xiaohua Hao3 1Beijing Ditan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Yangtze River Pharmaceutical Group Co, Ltd., Taizhou, People’s Republic of China; 3Beijing Shijitan Hospital, Capital Medica...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-06-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/pharmacokinetics-pharmacodynamic-safety-and-tolerability-of-fazamorexa-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|